Company intelligence / Profile preview

ArtiQ

Ownership: Private
Development stage: Other

Overview

ArtiQ’s AI-driven software is CE marked, ISO certified, and has been used in over 140,000 hospital test interpretations. It improves the accuracy of pulmonary function tests and automates quality assessment in both routine care and clinical trials. The technology is validated through scientific publications and international presentations. Its integration with Clario’s devices further enhances real-time feedback on data quality in respiratory trials.

Therapeutic areas: Pulmonology
Modalities: Non-pharmacological therapyAI Software
Industry: Physiological Monitoring

Partnerships

AstraZenecaKoneksaUniversity Hospitals Leuvenequipment manufacturers

Beyond the preview

Go deeper on ArtiQ.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArtiQ.

Explore the full profile